Enable Block: 

To address the fresh outbreak of Ebola Virus Disease (EVD) in the Democratic Republic of Congo (DRC), the World Health Organisation (WHO) may deploy an experimental Ebola vaccine against the scourg

WASHINGTON - A small outbreak of Ebola virus in Democratic Republic of the Congo is causing alarm among public health officials.

The United Nations' World Health Organisation has announced a second case of Ebola infection in northern Democratic Republic of Congo (DRC) after identifying over a dozen suspected cases in the pas

The Nigerian Medical Association (NMA) is finalising an arrangement to contain a possible spread of Ebola Virus Disease (EVD) following its recent outbreak in the Democratic Republic of Congo (DR C

LAGOS - Nigeria on Monday said it had stepped up health surveillance and vigilance at its entry ports after an Ebola outbreak in the Democratic Republic of Congo killed at least three people.

Monrovia - Foreign Affairs Minister Marjon Kamara has encouraged adolescent girls to make use of opportunities, adding that issues of women and girls empowerment is close to her heart.

South Asia despite decreasing rates of infectious disease, accounts for a significant proportion of their global burden. The sub-continent is also in the midst of rapid economic growth; large scale changes in land use, access to water and sanitation, and agricultural production; environmental degradation; and technological transformation, all against a background of uneven health system capacity. South Asia, defined by the World Bank as Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka, is home to a quarter of the world’s population.

The 2014–15 Ebola virus disease (EVD) epidemic strained health systems in west Africa already overburdened with other diseases, including malaria. Because EVD and malaria can be difficult to distinguish clinically, and rapid testing was not available in many Ebola Treatment Units (ETUs), guidelines recommended empirical malaria treatment. Little is known, however, about the prevalence and characteristics of patients entering an ETU who were infected with malaria parasites, either alone or concurrently with Ebola virus.

Global funding for research and development on neglected diseases reached a historic low in 2015, driven by declining public sector investment. The G-FINDER report by Australia-based independent group, Policy Cures Research, says that the decline is due to the lack of funding by rich countries. According to it, this is the lowest-ever funding on record by the US. Same can be said of the UK. The G-FINDER analysis tracks public and private investment in diseases that affect people in the developing countries. Over 1 billion people in 149 countries worldwide suffer from one or more neglected diseases, and they are now included in the Sustainable Development Goals.

The ninth G-FINDER survey reports on 2015 global investment into research and development (R&D) of new products for neglected diseases, and identifies trends and patterns across the nine years of global G-FINDER data.

Pages